<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01224938</url>
  </required_header>
  <id_info>
    <org_study_id>Biomarker sputum airway study1</org_study_id>
    <nct_id>NCT01224938</nct_id>
  </id_info>
  <brief_title>Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 1.</brief_title>
  <acronym>BioSput-Air</acronym>
  <official_title>Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 1.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objectives of the study are

        1. to study the different T cell subtypes (Th1, Th2, Th17 and Treg) in the lower airways of
           healthy subjects and clinically different asthma patients, based on a non-invasive
           procedure of sputum induction. Patients will be different in function of age, in
           relation to the trigger (eg aspirin, without or with association with polyposis),
           without or with underlying atopic sensitization or different in the type of underlying
           inflammation (eosinophilic vs neutrophilic). This T cell pattern will become the basis
           of molecular phenotyping in the patients.

        2. to study the usefulness of asthma molecular phenotyping (by following the balance
           between the inflammatory markers on the one hand and the regulatory markers on the other
           hand) in asthma guidance (longitudinally).

      The final goal of this project is then to develop a sputum non-invasive biomarker array that
      can be used to distinguish the different inflammatory asthma phenotypes and that can predict
      steroid resistance and/or sensitivity to other anti-inflammatory medication, using a
      non-invasive technique that can be used also at young age and repetitively.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">March 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>sputum cytokine mRNA</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>lung function parameters</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>asthma symptom scores</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>non-invasive measurements of airway inflammation</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">395</enrollment>
  <condition>Asthma Patients</condition>
  <condition>Healthy Subjects</condition>
  <arm_group>
    <arm_group_label>Asthma patients</arm_group_label>
    <description>Asthmatics of all classes of severity will be included.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy control population</arm_group_label>
    <description>A healthy control population will be included to compare with the asthmatics.</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      lysed sputum cells
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        330 asthmatics (300 adults, 30 children) will be recruited from the outpatient clinic of
        the university hospital of Leuven. 115 healthy subjects (100 adults, 15 children) will be
        recruited among students and co-workers from the KULeuven and UZ Leuven.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  asthma diagnosis

        Exclusion Criteria:

          -  viral/bacterial/fungal infection with fever (&lt;1 month )

          -  other airway diseases (CF, ciliar dyskinesia, bronchiectasis)

          -  asthma exacerbation (&lt;3 months)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominique MA Bullens, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lab of clinical immunology, O&amp;N I Herestraat 49 - bus 811, 3000 Leuven, België</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sven F Seys, MSc</last_name>
    <role>Study Director</role>
    <affiliation>Lab of clinical immunology, O&amp;N I Herestraat 49 - bus 811, 3000 Leuven, België</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital of Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Bullens DM, Decraene A, Dilissen E, Meyts I, De Boeck K, Dupont LJ, Ceuppens JL. Type III IFN-lambda mRNA expression in sputum of adult and school-aged asthmatics. Clin Exp Allergy. 2008 Sep;38(9):1459-67. doi: 10.1111/j.1365-2222.2008.03045.x. Epub 2008 Jun 28.</citation>
    <PMID>18564328</PMID>
  </reference>
  <reference>
    <citation>Bullens DM. Measuring T cell cytokines in allergic upper and lower airway inflammation: can we move to the clinic? Inflamm Allergy Drug Targets. 2007 Jun;6(2):81-90. Review.</citation>
    <PMID>17692031</PMID>
  </reference>
  <reference>
    <citation>Bullens DM, Truyen E, Coteur L, Dilissen E, Hellings PW, Dupont LJ, Ceuppens JL. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res. 2006 Nov 3;7:135.</citation>
    <PMID>17083726</PMID>
  </reference>
  <reference>
    <citation>Truyen E, Coteur L, Dilissen E, Overbergh L, Dupont LJ, Ceuppens JL, Bullens DM. Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients. Thorax. 2006 Mar;61(3):202-8. Epub 2006 Jan 31.</citation>
    <PMID>16449261</PMID>
  </reference>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 18, 2010</study_first_submitted>
  <study_first_submitted_qc>October 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2010</study_first_posted>
  <last_update_submitted>September 25, 2013</last_update_submitted>
  <last_update_submitted_qc>September 25, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 27, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitaire Ziekenhuizen Leuven</investigator_affiliation>
    <investigator_full_name>Dominque Bullens</investigator_full_name>
    <investigator_title>prof. dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

